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Oxidative damage to proteins can occur under physiological conditions through the action of
reactive oxygen species, including those containing nitrogen such as peroxynitrite (ONO2
2).
Peroxynitrite has been shown in vitro to target tyrosine residues in proteins through free
radical addition to produce 3-nitrotyrosine. In this work, we show that mass spectral patterns
associated with 3-nitrotyrosine containing peptides allow identification of peptides containing
this modification. Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry
was used to characterize a synthetic peptide AAFGY(m-NO2)AR and several peptides
containing 3-nitrotyrosine derived from bovine serum albumin treated with tetranitrometh-
ane. A unique series of ions were found for these peptides in addition to the mass shift of 145
Da corresponding to the addition of the nitro group. Specifically, two additional ions were
observed at roughly equal abundance that correspond to the loss of one and two oxygens, and
at lower abundances, two ions are seen that suggest the formation of hydroxylamine and
amine derivatives. These latter four components appear to originate by laser-induced
photochemical decomposition. MALDI-MS analysis of the synthetic peptide containing
3-nitrotyrosine revealed this same pattern. Post-source decay (PSD) MALDI-time-of-flight
(TOF) and collisional activation using a prototype MALDI quadrupole TOF yielded extensive
fragmentation that allowed site-specific identification of 3-nitrotyrosine. Conversion of pep-
tides containing 3-nitrotyrosine to 3-aminotyrosine with Na2S2O4 yielded a single molecular
ion by MALDI with an abundant sidechain loss under PSD conditions. These observations
suggest that MALDI can provide a selective method for the analysis and characterization of
3-nitrotyrosine-containing peptides. (J Am Soc Mass Spectrom 2001, 12, 439–448) © 2001
American Society for Mass Spectrometry
The nitration of tyrosine residues in proteins bynitrogen-containing reactive oxygen species toform 3-nitrotyrosine has been implicated as one
of several chemical modifications that can occur when a
cell or organism is experiencing oxidative stress [1].
Oxidative stress can be elevated in a specific disease
state or as part of the normal process of cellular metab-
olism and aging [2]. The conversion of tyrosine (Tyr) to
3-nitrotyrosine [Tyr(NO2)] may result in serious conse-
quences for a cell if specific proteins or enzymes are
modified that can lead to additional cell damage, pos-
sibly resulting in programmed cell death or apoptosis.
In support of the pathological role of tyrosine nitra-
tion in disease, 3-nitrotyrosine levels have been mea-
sured in various disease states or model systems and
found to be significantly elevated when compared to
appropriate controls. Immunohistological studies using
antinitrotyrosine antibodies, for example, have reported
elevated levels of proteins containing 3-nitrotyrosine in
Alzheimer’s disease [3, 4], atherosclerosis [5, 6], acute
lung disease [7], and amyotrophic lateral sclerosis (ALS)
[8, 9]. Chromatography-based methods have also been
used to measure levels of 3-nitrotyrosine and, when
coupled with electrochemical detection, studies have
found higher levels of free [10] and/or protein-bound
3-nitrotyrosine [11, 12] in ALS and Alzheimer’s disease.
More recently, isotopic dilution gas chromatography-
mass spectrometry (GC-MS), with arguably the highest
level of combined sensitivity and selectivity, found
increased levels of 3-nitrotyrosine (and o,o9-dityrosine)
in a mouse model of Parkinson’s disease [13].
The actual species that carries out the nitration of
tyrosine residues under physiological conditions has
been difficult to determine although several reactive
nitrogen species have been implicated such as NO2
z ,
N2O3, and peroxynitrite (ONO2
2). Peroxynitrite, a
highly reactive nitrogen species with a half-life of ;1 s
at physiological pH, has been suggested to be the major
contributor to this process [1]. Peroxynitrite may be
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formed in vivo from superoxide and nitric oxide (NOz)
(eqs 1 and 2) [14] and has been shown to form 3-nitro-
tyrosine from free tyrosine in solution and tyrosine
residues in various proteins (see Figure 1):
NOz 1 O2
2z3 ONOO2 (1)
H1 1 ONOO2 1 Tyr3 Tyr(NO2) 1 H2O (2)
This reaction can even occur at a faster rate than the
reaction of superoxide with superoxide dismutase.
Moreover, nitric oxide synthase is inducible in some
disease states, which would be expected to lead to
further increases in the overall levels of nitric oxide and
peroxynitrite [15]. Once formed, 3-nitrotyrosine may be
enzymatically reduced to form the nitro anion radical
(Tyr-NO2
2z), which in turn can be oxidized with O2 to
form superoxide anion (O2
2z) (eqs 3 and 4), further
elevating the levels of reactive oxygen species and
oxidative stress in the cell [16]:
Tyr(NO2) 1 e23 Tyr(NO2
2z) (3)
Tyr(NO2
2z) 1 O23 Tyr(NO2) 1 O2
2z (4)
In addition to this pathway, myeloperoxidase in neu-
trophils and monocytes has also been shown to be
capable of nitrating tyrosine in proteins through two
possible pathways [17]; one through the formation of
nitryl chloride and the other through oxidation of nitrite
and tyrosine.
Once formed, both free and protein-bound nitroty-
rosine are relatively stable products and may be an
important biomarker of overall oxidative stress or spe-
cific disease states. In a few cases, specific proteins have
been identified as targets of in vivo tyrosine nitration.
Such native protein targets include Mn-SOD [18], ty-
rosine hydroxylase [19], sarcoplasmic reticulum Ca-
ATPase [20], and the plasma proteins human serum
albumin [21] and low density lipoprotein [22]. Other
studies have examined the formation of protein-bound
nitrotyrosine under a variety of in vitro and in vivo
conditions. Most of these studies have employed im-
muno-histochemical or ELISA techniques, or chromato-
graphic methods using either high performance liquid
chromatography (HPLC) separation combined with
electrochemical detection or GC-MS techniques (for
recent reviews, see [23, 24]). For these latter chromatog-
raphy-based methods, the level of protein-bound 3-ni-
trotyrosine is determined after its release by acid or
enzymatic hydrolysis of protein mixtures. However,
many of these analytical methods have led to the
reports of 3-nitrotyrosine levels that are vastly different,
especially in protein-bound 3-nitrotyrosine levels. Sev-
eral recent reports have shown that artifacts can arise
through the production of 3-nitrotyrosine during vari-
ous isolation or derivatization steps or from co-eluting
contaminants that may have been incorrectly assigned
[25]. Nitrotyrosine levels as determined by both GC-MS
or LC procedures, for example, have been found to be
highly sensitive to background levels of nitrate and
nitrite, which can form 3-nitrotyrosine under acid hy-
drolysis conditions [24, 26, 27].
An alternative method to examining overall levels of
3-nitrotyrosine in proteins would be to identify these
modification directly for the various potential tyrosine
sites within any given protein. Although a much more
challenging analytical task, obtaining site-specific infor-
mation is likely to be considerably more informative as
an oxidative biomarker than overall 3-nitrotyrosine
levels. Some previous studies have examined specific
proteins after in vitro treatment with peroxynitrite or
tetranitromethane by electrospray mass spectrometry,
including superoxide dismutase [28, 29], surfactant pro-
tein A [30], nonadenylated glutamine synthetase [31],
and peptides such as angiotensin [32] and the enkepha-
lins [33]. In all of these studies, a characteristic addition
of 45 Da to the molecular ion of the modified peptide
containing the nitro-substituted tyrosine group was
observed, providing unequivocal evidence for the pres-
ence of this modification and suggesting that mass
spectrometry of intact peptides (or proteins) might be a
suitable analytical alternative.
In this paper, we report the analysis of peptides
containing 3-nitrotyrosine by matrix-assisted laser de-
sorption/ionization (MALDI) mass spectrometry and
show that a specific and unique molecular ion series is
obtained that can be used to identify these modifica-
tions, even in mixtures. We also show that if 3-nitroty-
rosine is converted to 3-aminotyrosine in peptides us-
ing standard protocols [34], the accompanying mass
shift can be used to identify 3-nitrotyrosine-containing
peptides.
Experimental
Materials
Nitrotyrosine and trypsin were obtained from Sigma
(St. Louis, MO). Tetranitromethane, ammonium bicar-
bonate, and sodium dithionite (or sodium hydrosulfite,
Na2S2O4) were obtained from Aldrich (Milwaukee, WI).
Figure 1. A proposed route for the in vivo formation of nitroty-
rosine from peroxynitrite and tyrosine (adapted from ESA,
Chelmsford, MA, “Measurement of 3-Nitrotyrosine” 1998). Per-
oxynitrite may form a nitroniumlike ion, NO2
1 (a potent electro-
phile), through metal-catalyzed heterolytic cleavage or can attack
tyrosine directly through a radical mechanism.
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The model nitrotyrosine-containing tryptic peptide,
AAFGY(m-NO2)AR, was obtained from Genosys
(Woodlands, TX) via custom commercial synthesis.
HPLC-grade acetonitrile and water was purchased
from Fisher Scientific (Pittsburg, PA). Trifluoroacetic
acid was obtained from Pierce (Rockport, IL). Bovine
serum albumin (BSA) used to prepare nitrated BSA was
obtained from Boehringer Mannheim (Indianapolis,
IN). The MALDI matrices a-cyano-4-hydroxycinnamic
and 2,5-hydroxy benzoic acid was obtained from
Hewlett Packard (Palo Alto, CA) and Aldrich, respec-
tively.
Methods
Nitration of BSA. One mL of a bovine serum albumin
(5 mg/mL) in 10 mM ammonium bicarbonate buffer
(pH 8) was reacted with 5 mL of tetranitromethane
dissolved in 95% alcohol as previously described [35].
After 1 h the reaction was quenched with acetic acid
and the nitrated BSA was separated from nitroformate
using a size exclusion chromatography (Bio-Gel P-6).
The fraction obtained with similar retention time to the
native BSA run as a reference, was lyophilized over-
night. (Purified nitrated BSA was yellowish in appear-
ance compared to unmodified BSA, which has no
color.)
Tryptic hydrolysis and HPLC separation of nitrated-BSA.
Trypsin digestion of BSA and nitrated BSA proceeded
at 37 °C with a trypsin/protein ratio of ;1:20 (w/w) for
16 h. The enzymatic digestion was stopped by freezing
followed by lyophilization. The tryptic hydrolyzate
consisting of both unmodified and modified peptides
was then separated by reverse-phase HPLC. For off-line
analysis by MALDI-MS, a Rainin gradient HPLC (Em-
eryville, CA) was fitted with a C18 reverse-phase col-
umn (Vydac; Hesperia, CA). Peptides were eluted at a
flow rate of 1 mL/min under gradient conditions;
10%–90% B in 60 min where solvent A consisted of 0.1%
TFA in water and solvent B 0.08% TFA in 70% acetoni-
trile. Eluate was monitored at 210 nm (0.2 AUFS) with
an ABI 785A absorbance detector (Applied Biosystems;
Foster City, CA) and fractions were collected.
Reduction of nitrotyrosine to aminotyrosine. The reduc-
tion of peptides containing 3-nitrotyrosine to 3-amin-
otyrosine was accomplished by adding reducing agent
(Na2S2O4) to the peptide mixture or synthetic peptide
according to previously published methods [34]. No
cleanup was necessary if analyzed by MALDI-TOF,
although a solid phase extraction cleanup using re-
verse-phase Zip-Tips (Millipore; Bedford, MA) was
employed to improve peptide signal abundance or if
the peptides were analyzed by ESI-MS.
Mass spectrometry. All linear, reflectron, and PSD spec-
tra were acquired on a Applied Biosystems (Framing-
ham, MA) DE-Voyager or STR MALDI-TOF mass spec-
trometer equipped with delayed extraction optics and a
nitrogen laser. A prototype MALDI orthogonal quad-
rupole-TOF (or Q-TOF) based on a Mariner orthogonal
TOF mass spectrometer was used to obtain a collisional
induced dissociation (CID) spectrum of the synthetic
nitrotyrosine-containing peptide. This prototype
Q-TOF instrument was also equipped with a standard
nitrogen laser (337 nm) and data acquired in the posi-
tive-ion mode with external calibration. For the trypsin
digest of BSA and nitrated BSA, a 1 mL aliquot of the
total mixture or selected HPLC fraction was mixed with
33 mM a-cyano-4-hydroxycinnamic acid in acetoni-
trile/methanol (1/1; v/v) and air dried on a stainless
steel MALDI target. For the concentration dependence
studies of the synthetic peptide, AAFGY(m-NO2)AR, a
7.5 mM solution of peptide was prepared in water (0.6
mg/0.1 mL) and aliquots were diluted in successive
10-fold increments down to 7.5 nM. In each case, 1 mL of
the peptide solution was mixed with 2 mL matrix (33
mM a-cyano-4-hydroxycinnamic acid), and 1 mL was
deposited on the MALDI target covering a sample
range of 2.5 nmol to 2.5 fmol of total peptide spotted.
For the analysis of intact BSA samples (untreated and
nitrated), protein was mixed with saturated sinapinic
acid in 1:1 water/acetonitrile (v/v) and externally cali-
brated.
For ESI-MS analysis, peptide containing 3-nitroty-
rosine or the corresponding reduced 3-aminotyrosine
derivatives were analyzed on a Mariner orthogonal
TOF mass spectrometer (Applied Biosystems; Framing-
ham, MA) equipped with an electrospray source oper-
ating in the positive-ion mode. Solvents were water/
methanol or water/acetonitrile for infused samples
with a flow rate of ;5 mL/min. All mass spectra were
externally calibrated.
Results and Discussion
In this work, we have investigated the use of MALDI
mass spectrometry for the detection and characteriza-
tion of 3-nitrotyrosine modification at the peptide and
protein level.
When BSA was treated with tetranitromethane, the
linear MALDI-MS spectrum of nitrated BSA showed a
slight increase in the mass (;420 Da) relative to unre-
acted BSA with a noticeable broadening and tailing of
the unresolved isotope cluster (Figure 2). After proteol-
ysis of untreated and nitrated BSA with trypsin, the un-
separated peptide mixtures were analyzed by MALDI-
TOF (see Figure 3). Both MALDI-TOF spectra revealed a
number of (M 1 H)1 ions that could be readily assigned
to the sequence of BSA. However, in the tryptic digest of
the nitrated BSA sample, several changes were evident.
First, two (M 1 H)1 ions seen in the unreacted BSA
digest at m/z 927.4 and 1479.4 that correspond to the pre-
dicted tryptic peptides Y161LYEIAR167 (m/z calc. 927.5) and
L421GEYGFQNALIVR433 (m/z calc. 1479.8), respectively,
were significantly reduced in relative ion abundance.
Second, two new ions appear in the same mass regions
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that would nominally correspond to the substitution of
a hydrogen with NO2 (DM 5 45 Da) at m/z 972.5 and
1524.6, as would be expected if 3-nitrotyrosine were
present in these peptides. Third, these two new nitro-
tyrosine-containing peptide (M 1 H)1 ions appear to
have associated ions that are 16 and 32 Da lower in
mass, i.e., m/z 956.5 and 940.5 for the (M 1 H)1 ion at
m/z 972.5, and m/z 1508.6 and 1492.8 for the (M 1 H)1
ion at m/z 1524.6. Fourth, an analogous set of ions at
m/z 1484.6, 1468.5, and 1452.4 can be tentatively
identified as associated with the tryptic peptide
R360HPEYAVSVLLR371 at m/z 1439.8 (m/z calc. 1439.8),
but at very low relative ion abundance.
To investigate the origin of the prompt fragments
associated with the 3-nitrotyrosine-containing peptides
in more detail, a peptide containing nitrotyrosine was
synthesized and subsequently analyzed by MALDI-MS
and MALDI-PSD. As shown in Figure 4, MALDI-MS
analysis of this synthetic peptide, AAFGY(m-NO2)AR
(Mr 5 799.4), under both linear and reflectron condi-
tions revealed an abundant protonated molecular ion at
m/z 800.4, as well as several lower mass ions at m/z 786,
784, 770, and 768. Under the higher resolving condition
of the reflectron experiment, these ions were more
clearly defined, with the exception of the ion at m/z 786,
which appears not to have been stable enough to
survive the reflectron experiment and whose abun-
dance is now consistent with normal isotopic pattern of
the m/z 784 peak. In addition to these ions, a few small
and unfocused ions are seen in the reflectron spectrum
that suggest various metastable processes are also oc-
curring. For example, an ion is observed at m/z 768.7,
between the m/z 768.4 ion and its C-13 isotope at m/z
769.4, that is skewed and at a mass inconsistent with the
elemental composition of the peptide.
Taken together, these data suggest that 3-nitroty-
rosine [Tyr(NO2), 1] is undergoing a series of photode-
composition reactions involving the loss of one or two
oxygens that can also be accompanied by further reduc-
Figure 2. Linear positive-ion MALDI spectra of BSA and nitrated
BSA (N-BSA). The measured singly charged molecular ions were
m/z 66,438 for BSA (vs. m/z 66431, calculated) and m/z 66, 857 for
N-BSA (DM 5 419 Da).
Figure 3. Linear positive-ion MALDI spectra of an unseparated
tryptic digest of (a) BSA and (b) nitrated BSA. The (M 1 H)1 ions
at m/z 927.4 and 1479.8 are significantly reduced in abundance in
the nitrated BSA digest (bottom spectrum), and by three new ions
(denoted with an asterisk) corresponding to the nitration (145 Da)
tyrosine at m/z 972.5.1, 1484, and 1524.6, respectively. Associated
with each of these three new molecular ion are ions 16 Da (m/z
956.5, and 1468.5 and 1508.6; filled circle) and 32 Da (m/z 940.5,
1452.4 and 1492.8; open circle) lower in mass, respectively. See text
for details.
Figure 4. Molecular ion region of MALDI-TOF spectrum of
synthetic peptide AAFGY(NO2)AR taken in the (A) linear mode
and (B) reflectron mode. The structure of 3-nitrotyrosine and the
proposed photodecomposition products are shown next to the
various ions. Several small ions are labeled with an asterisk that
may represent metastable peaks (see text for details). A slight
increase in the abundance of the ion at m/z 771.4 over what would
be expected for the C-13 isotope peak for the amino-tyrosine
products at m/z 770.4 in both the linear and reflectron spectra
suggest that a small amount of a catechol product may have
formed as well.
442 SARVER ET AL. J Am Soc Mass Spectrom 2001, 12, 439–448
tive reactions. These processes are summarized in
Scheme 1. The loss of a single oxygen from the aromatic
nitro group to form the nitroso analog [Tyr(NO), 2] is
relatively straightforward and can be rationalized as
involving a two electron reduction process accompa-
nied by the transfer of two protons and loss of water.
Such a pathway is a common photodecomposition
product of many nitroaromatic compounds in the pres-
ence of proton donors (see review [36]), which in this
case would be the MALDI matrix and/or residual
solvent.
Alternatively, 2-nitrophenol has been previously
shown to form nitrosophenol in aqueous solution in a
photochemical process via homolytic scission of a
N–O2 bond followed by reduction of the radical inter-
mediate by species present in solution [37] (see Scheme
2). And, as mentioned before, the MALDI matrix could
serve as the source of hydrogens for the reduction
process.
Lastly, the formation of reduced analogs containing
hydroxylamine [Tyr(NHOH), 3] and amine [Tyr(NH2),
4] ring substituents likely result from further reduction
steps involving the transfer of an additional two and
four electrons.
The loss of two oxygens from the nitrotyrosine side
chain is more problematic, and probably involves mul-
tiple steps. It is conceivable that the second loss of
oxygen could involve participation of the neighboring
hydroxyl group, accompanied by a reduction step from
the matrix. Alternatively, the second oxygen loss might
arise through the analogous reaction, described previ-
ously, for the photodecomposition of 3-nitrotyrosine to
3-nitrosotyrosine that relies on the acidic nature of the
ortho phenolic group. Such a process is shown in
Scheme 3 where the nitrosotyrosine analog (2) is in
equilibrium with its deprotonated form which could
then undergo homolytic scission of the N–O2 bond and
possible reduction of the triplet nitrene [Tyr(N), 5].
In support of this latter process, a relatively stable
triplet phenyl nitrene (or its rearranged seven ring
membered isomer “dehydroazepine”) has been re-
ported in the photodecomposition of phenyl azides [38]
(see Scheme 4). Therefore, it is likely that the com-
pounds corresponding to the loss of two oxygens from
nitrotyrosine peptides contain either a nitrene (5) or
dehydrozepine-type side chain (6).
To examine the effects of time (i.e., number of laser
shots), laser power, and peptide concentration on the
formation of these photodecomposition fragments, a
series of linear MALDI-MS experiments were carried on
the synthetic peptide, AAFGY(m-NO2)AR. The effects
of timing or numbers of laser shots on the relative
abundance of the molecular ion and photodecomposi-
tion products were examined by integrated successive
sets of laser pulses at the same spot (16 shots each). For
these experiments, we saw no difference in the first
spectrum (first 16 shots) compared to successive sets of
integrated spectra (shots 17–32, 33–48, etc.). Likewise,
laser power seemed to have no discernable effect on the
relative abundances of these species; an increase in laser
fluence from threshold levels and higher increased both
the molecular ion and products to the same extent.
However, a marked difference in the molecular ion
region was observed when the peptide concentration
(or amount spotted) was varied (Figure 5). At very high
amounts (2.5 nmol/1 mL, Figure 5A), the 230/32 Da
photodecomposition products [Tyr(NH2) and Tyr(N), 4
and 5] were considerably lower in abundance than both
the molecular ion and the 214/16 Da products
Scheme 1
Scheme 2
Scheme 3
Scheme 4
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Tyr(NHOH) and [Tyr(NO), 3 and 2]. At successive
10-fold dilutions to 2.5 pmol, the abundance of the
230/32 Da photodecomposition product ions (4 and 5)
steadily increased to levels approximately equal to the
214/16 products (3 and 2), whereas the relative abun-
dance of the molecular ion decreased ;2–3 fold. At
even lower sample loadings (i.e., 0.25 pmol to 25 fmol,
data not shown), the relative abundances of the parent
and product ions remained essentially identical to that
obtained at the 2.5 pmol peptide level (see Figure 5c).
To investigate the thermal fragmentation behavior of
peptides with 3-nitrotyrosine sidechains, post-source
decay analysis of the model nitrotyrosine-containing
tryptic peptide, AAFGY(m-NO2)AR, was carried out
with mass selection of the precursor ions for the parent
and several decomposition products. In the first exper-
iment, timed-ion selection was set to pass the parent
nitrotyrosine-containing ion at m/z 800. In this spec-
trum, shown in Figure 6a, an extensive series of frag-
ment ions were obtained consisting primarily of y- and
b-type ions and several internal peptide fragments. In
the second experiment, timed-ion selection was set to
pass both the m/z 784 and 786 ions, but also passed the
higher mass m/z 800 ion and lower mass ion pair at m/z
768 and 770 (data not shown). The third experiment was
setup to select the two low mass ions at m/z 770 and 768,
the aminotyrosine [Tyr(NH2)] and Tyr(N)-containing
photodecomposition products, with minimal overlap of
the higher mass species (see Figure 6b). Similarly, this
latter spectrum also contained abundant y and b ions
with several internal peptide fragments. However, a
very abundant ion was observed at m/z 648 that would
nominally correspond to the complete sidechain loss of
3-aminotyrosine, i.e., m/z 770 2 1223 m/z 648 and m/z
768 2 1203 m/z 648. Moreover, the fragments contain-
ing the modified tyrosine residue appear as doublets,
suggesting that little post-ionization reduction had en-
sued that might convert the 1-hydroxyphenyl nitrene
(or the dehydroazepine isomer) sidechain to the pre-
sumably more stable 3-aminotyrosine sidechain. Lastly,
the abundant fragment ion at m/z 272 would nominally
correspond to a b3 2 H2O ion, but because this ion is
absent in the PSD from the parent ion (Figure 6a), it is
more likely to be a y2 1 26 (also called x3) ion that is
usually observed only under high-energy fragmenta-
tion conditions. This ion might be favored in this case
by a reaction process that is dependent on the prior loss
of the neighboring Tyr(NH2) and Tyr(N) sidechains,
followed by homolytic cleavage between the resulting
radical C-alpha carbon and the adjacent C-terminal
carbonyl.
Closer examination of the low mass immonium ion
region of these three PSD spectra also contained informa-
tion on the modified tyrosine residue. In the MALDI-PSD
spectrum of the parent 3-nitrotyrosine containing peptide
(Figure 7a), an ion is present that corresponds to the
expected immonium ion at m/z 181 for 3-nitrotyrosine,
1H2N¢CH–CH2–C6H3(OH)(NO2), (7). When only the
lower two masses at m/z 768 and 770 were selected
for PSD, new ions at m/z 149 and 151 are observed
corresponding to 1H2N¢CH–CH2–C6H3(OH)(N) and
1H2N¢CH–CH2–C6H3(OH)(NH2), compounds 9 and/or
10, and 11, respectively (Figure 7c). When the nitroso- and
hydroxylamine-tyrosine photodecomposition products at
Figure 5. Changes in the relative ion abundances of the molec-
ular ion (m/z 800.4) and photodecomposition products (m/z 786.3,
784.3, 770.3, and 768.3) for peptide AAFGY(NO2)AR under linear
MALDI-MS conditions at different loading amounts (concentra-
tions). Amounts spotted are (a) 2.5 nmol, (b) 0.25 nmol, and (c) 2.5
pmol.
Figure 6. MALDI-TOF spectra with PSD of synthetic peptide
AAFGY(NO2)AR. Timed ion selection set for transmission of
precursor ions at (a) m/z 800.4 Da and (b) 768.4 Da and 770.4. See
text for details.
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m/z 784 and 786 were optimized for PSD ion selection,
an immonium ion for nitrosotyrosine, 1H2N¢CH–CH2–
C6H3(OH)(NO) (8), at m/z 165 was now observed (Fig-
ure 7B), but not the analogous hydroxylamine analog
(m/z 167, not observed). Scheme 5 summarizes the likely
structures of these immonium ions.
At this point, we examined several of the peptides
containing 3-nitrotyrosine from the original tryptic hy-
drolyzate of tetranitromethane-treated BSA by MALDI-
PSD. To obtain better primary ion signals, these pep-
tides were first separated from the total tryptic
hydrolyzate by HPLC separation while monitoring the
eluant at 450 nm. Nitroaromatics are known to have a
strong UV absorption at this wavelength; this allowed
us to identify the elution positions of “nitrated” tryptic
peptides in this complex mixture with relative selectiv-
ity (data not shown). Three peptides were subsequently
isolated and were found to yield the same mass signa-
ture pattern [i.e., triplet set of molecular ions], two of
which had been clearly identified by MALDI analysis of
the unseparated digest, i.e., m/z 972 (and 956 and 940)
and 1524 (and 1508 and 1492). The third HPLC isolated
peptide fraction yielded three major ions at m/z 1484,
1468, and 1452, which had only been tentatively iden-
tified in the unseparated digest. This latter set of ions
could now be unequivocally assigned to the peptide
R360HPEY(NO2)AVSVLLR
371. These PSD experiments
also yielded spectra with extensive fragmentation that
allowed for the position of the modification to be
determined. For example, MALDI-PSD analysis of one
of these peptides, Y161LYEIAR167 whose mass is consis-
tent with a single nitrated tyrosine residue at m/z 972.4,
is shown in Figure 8. In this experiment, the lower mass
photodecomposition product ions at m/z 940 and 942
(loss of two oxygens with partial reduction to aminoty-
rosine, respectively) were selected as this was experi-
mentally easier to accomplish given the large mass
window of timed-ion selection. In the resulting MALDI-
PSD spectrum, the presence of a complete y-ion series
allows us to establish that the first tyrosine residue
(tyrosine-161) contains the nitro group modification,
Y161(NO2)LYEIAR
167. The absence of doublet ions sep-
arated by 2 Da in the y-ion series also supports this
interpretation because doublets corresponding to the y5
and y6 would appear if the second internal tyrosine
(tyrosine-163) was nitrated.
To gain better mass selectivity and mass accuracy,
the synthetic 3-nitrotyrosine-containing peptide
AAFGY(m-NO2)AR was first analyzed under mass spec-
trometry conditions and then the nitrotyrosine-contain-
ing peptide was subjected to CID analysis using a
prototype quadrupole-orthogonal TOF mass spectrom-
eter with a MALDI source (see Figure 9). As before,
Figure 7. Comparative immonium ion regions for the precursor
(parent) ions at (a) m/z 800, (b) m/z 786 and 784 (with m/z 880, 770,
and 768), and (c) m/z 770 and 768. Likely structures of nitroty-
rosine and corresponding photochemical decomposition product
immonium ions are shown next to the corresponding masses and
in Scheme 5.
Scheme 5
Figure 8. MALDI-PSD spectrum of BSA tryptic peptide
Y(NO2)LYEIAR (with timed ion selection of the lowest mass
photodecomposition components (M 1 H 2 30)1 and (M 1 H 2
32)1 at m/z 942.4 and 940.4.
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three dominant ions were observed in the normal
MALDI-MS spectrum at m/z 800.4, 784.4, and 768.4 (the
expected molecular ion triplet is shown in the inset to
Figure 9, top right), with some indication of ions at m/z
770.4 and 786.4. To obtain the corresponding tandem
mass spectrum, the precursor ion at m/z 800.4 was
selected by the quadrupole analyzer (61 Da mass
selection window), collisionally activated, and the re-
sulting fragments separated on the TOF analyzer. In
this MS/MS spectrum, no ions were seen correspond-
ing to the loss of 16 or 32 Da from the parent ion, as
might be expected if these lower mass ions were ther-
mal (prompt) fragments. The sidechain loss of nitroty-
rosine was also largely absent. However, in the low
mass region, an immonium ion is seen at m/z 181.1
corresponding to 3-nitrotyrosine, 1H2N¢CH–CH2–
C6H3(OH)(NO2), 7 (see inset in Figure 9, top left). In
addition, an abundant series of fragment ions corre-
sponding to the y- and b-ion series was observed,
allowing for the complete sequence determination of
this peptide. For example, the b4 and b5 ions at m/z 347.2
and 555.2, and the y2 2 NH3 and y3 2 NH3 ions at m/z
229.1 and 437.2, respectively, yield the unique mass
difference of 3-nitrotyrosine with a residue mass of
208.1 Da.
Conversion of the synthetic 3-nitrotyrosine-contain-
ing peptide to the corresponding 3-aminotyrosine de-
rivative was carried out with Na2S2O4 and no purifica-
tion or cleanup was required prior to mass
spectrometry analysis. The reaction appeared to be
quantitative because only a single molecular ion was
observed by MALDI-MS at m/z 770.5 (data not shown).
Similar results were observed with the nitrated BSA
tryptic digest after reduction. PSD analysis of the mo-
lecular ion for the synthetic peptide (Figure 10) resulted
in a spectrum that recapitulates many features seen in
the MALDI-PSD spectrum of the photodecomposition
products of the nonreduced nitrotyrosine peptide at m/z
768 and 770 (see Figure 6b). In addition to an abundant
y- and b-type ion series, the most abundant fragment
was the sidechain loss of aminotyrosine, which was also
the major fragment observed for the photodecomposi-
tion product spectrum.
Reduction of the tryptic hydrolyzate of nitrated BSA
with sodium dithionite also showed a shift to a single
ion 30 Da lower in mass for the corresponding 3-nitro-
tyrosine-containing peptides, i.e., m/z 972.43 942.4 and
m/z 1524.9 3 1494.8. The ions previously identified as
arising from photodecomposition of these nitrated pep-
tides, i.e., 16 and 32 Da lower in mass, were now absent
(data not shown).
When the amino- and nitrotyrosine-containing pep-
tides (synthetic and BSA derived) were analyzed under
ESI MS ionization, the reduced aminotyrosine peptide
also displayed an experimental mass 30 Da lower than
the corresponding nitrotyrosine-containing peptides.
Therefore, by both MALDI and ESI, the aminotyrosine
derivative yields a single molecular ion species corre-
sponding to the expected mass for these peptides,
whereas the 3-nitrotyrosine containing peptides do so
only under ESI conditions.
Conclusions
Under standard MALDI conditions using a nitrogen
laser (337 nm), a set of photochemical reaction products
has been observed for peptides containing nitroty-
rosine. Under positive ionization conditions, the ex-
pected molecular ion corresponding to the presence of
the intact sidechain for 3-nitrotyrosine is observed for
these peptides as well as several prominent decompo-
sition products involving the loss of one and two
Figure 9. Tandem MALDI-Q-TOF spectra of synthetic peptide
AAFGY(N)AR with the MH1 ion at m/z 800.4 selected for colli-
sional activation. Boxed inset (top right) shows the molecular ion
region of normal MALDI-MS scan from which the precursor ion at
m/z 800.4 was selected for the subsequent MS/MS experiment.
Note the absence of the 216 (m/z 784) and 232 (m/z 768)
photodecomposition fragments in the resulting MS/MS spectra.
Inset on top left shows expanded region (310) of the MS/MS
spectrum containing the nitrotyrosine immonium ion at m/z 181.
Figure 10. MALDI-TOF with PSD of reduced 3-nitrotyrosine
peptide AAFGY(NH2)AR. Note the abundant ion at m/z 648 (2Y*)
corresponding to the loss of the aminotyrosine side chain.
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oxygens (216 and 232 Da, respectively). In addition,
reduction of these two species lead to the formation of
species that incorporate two hydrogens each (214 and
230 Da, respectively). The structures of these decom-
position products are not known with certainty, but the
loss of one oxygen from nitroaromatics to form the
nitroso analog is well-established [36], as is the subse-
quent formation of the hydroxylamine derivative. The
loss of two oxygens is more problematic, but phenyl
nitrene and the seven-membered ring rearrangement
product dehydroazepine have been reported in the
decomposition of phenylazide and may be stable
enough under these conditions to survive on the time
scale of the MALDI experiment. In addition, the forma-
tion of immonium ions at low mass region of the spectra
recapitulates these processes, yielding the expected
immonium ion for 3-nitrotyrosine and the associated
photodecomposition products with the exception of the
hydroxylamine derivative, whose corresponding pep-
tide molecular ion does not survive the reflectron
experiments.
The unique molecular ion photodecomposition
products by MALDI-MS provides a unique signature
for peptides containing 3-nitrotyrosine observed and
therefore unequivocal evidence for the presence or
absence of 3-nitrotyrosine in a given peptide. Although
this triplet signature does offer selectivity advantages,
the molecular ion current is now spread out among at
least three major species compared to nonnitrated pep-
tides. Although this effect could also be seen as lower-
ing the absolute signal abundance (i.e., lower sensitiv-
ity) by as much as 60%–70%, one could also argue that
the triplet pattern could be leveraged to enhance overall
detection. We are currently investigating such a strat-
egy.
Using nitrated BSA as a test case, MALDI-MS was
shown to be capable of identifying nitrotyrosine modi-
fications in a complex peptide mixtures. Moreover, the
unique immonium ion fragments in the low mass
region of PSD and other types of MS/MS or collision-
ally activated spectra provide additional or comple-
mentary evidence for the presence of 3-nitrotyrosine in
a peptide. However, in relevant biological samples,
global levels of nitrotyrosine have been estimated to be
as low as 1 in 106 [21, 39], much lower than encountered
here. Although nitrotyrosine modifications are likely to
be higher for individual proteins and/or specific ty-
rosine residues, the analysis of such modifications with-
out some enrichment procedure (e.g., immunoprecipi-
tation) remains highly problematic and a serious
challenge for future experiments. Two such on-going
studies in our laboratory, one examining nitrotyrosine
modifications in mitochondrial proteins from a SOD
knockout mouse model [40] and the other examining
plasma proteins in Alzheimer’s patients, will attempt to
address these issues.
The reduction of 3-nitrotyrosine-containing peptides
with sodium dithionite quantitatively converts these
nitrotyrosine-containing peptides to their amino-ty-
rosine analogs. Under ESI-MS conditions, both the
nitrotyrosine and amino-tyrosine peptides give rise to
single molecular ions, but differ by 30 Da as expected
from the difference in their molecular weights. Under
MALDI conditions, peptides containing 3-aminoty-
rosine are observed 30 Da lower in mass from their
3-nitrotyrosine analogs and do not appear to undergo
photodecomposition reactions. This mass shift could
potentially be used to identify peptides containing
nitrated tyrosine via examination of molecular ion
profiles of peptides before and after reduction.
Together, the observations in this current study
show that MALDI (and ESI) mass spectrometry can
provide a highly selective method for the analysis and
characterization of peptides containing 3-nitrotyrosine.
And with additional work, MALDI-MS could possibly
be developed into a useful experimental protocol to
monitor oxidative damage at the peptide-protein level
as a biomarker of oxidative stress or disease.
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